Impact of clinical features of epidermal growth factor receptor (EGFR)-mutated non-small cell lung cancer (NSCLC) patients on osimertinib efficacy

by Lazzari, Chiara, Gregorc, Vanesa, Santarpia, Mariacarmela
Published in J Thorac Dis (2019)

Peptide-Mediated Targeting of Cytokines to Tumor Vasculature: The NGR-hTNF Example

by Corti, Angelo, Curnis, Flavio, Rossoni, Gilda, Marcucci, Fabrizio, Gregorc, Vanesa
Published 2013

Osimertinib in untreated epidermal growth factor receptor (EGFR)-mutated advanced non-small cell lung cancer

by Gregorc, Vanesa, Lazzari, Chiara, Karachaliou, Niki, Rosell, Rafael, Santarpia, Mariacarmela
Published in Transl Lung Cancer Res (2018)

Mechanisms of resistance to osimertinib

by Lazzari, Chiara, Gregorc, Vanesa, Karachaliou, Niki, Rosell, Rafael, Santarpia, Mariacarmela
Published in J Thorac Dis (2020)

Temozolomide in combination with either veliparib or placebo in patients with relapsed-sensitive or refractory small-cell lung cancer

by Lazzari, Chiara, Gregorc, Vanesa, Bulotta, Alessandra, Dottore, Alessia, Altavilla, Giuseppe, Santarpia, Mariacarmela
Published in Transl Lung Cancer Res (2018)

Combined exosomal RNA and circulating tumor DNA for epidermal growth factor mutation detection in non-small cell lung cancer

by Lazzari, Chiara, Gregorc, Vanesa, Cangi, Maria Giulia, Giovannetti, Elisa, Bulotta, Alessandra, Santarpia, Mariacarmela
Published in J Thorac Dis (2018)

Targeted Therapies in Early Stage NSCLC: Hype or Hope?

by Friedlaender, Alex, Addeo, Alfredo, Russo, Alessandro, Gregorc, Vanesa, Cortinovis, Diego, Rolfo, Christian D.
Published in Int J Mol Sci (2020)

Lung cancer screening: who pays? Who receives? The European perspectives

by Novellis, Pierluigi, Cominesi, Silvia Raimondi, Rossetti, Francesca, Mondoni, Michele, Gregorc, Vanesa, Veronesi, Giulia
Published in Transl Lung Cancer Res (2021)

Clinical Significance of Skin Toxicity due to EGFR-Targeted Therapies

by Giovannini, Monica, Gregorc, Vanesa, Belli, Carmen, Roca, Elisa, Lazzari, Chiara, Viganò, Maria Grazia, Serafico, Anna, Villa, Eugenio
Published 2009

Historical Evolution of Second-Line Therapy in Non-Small Cell Lung Cancer

by Lazzari, Chiara, Bulotta, Alessandra, Ducceschi, Monika, Viganò, Maria Grazia, Brioschi, Elena, Corti, Francesca, Gianni, Luca, Gregorc, Vanesa
Published in Front Med (Lausanne) (2017)

Immunohistochemical Evaluation and Clinicopathological Correlation of Mer and Axl Tyrosine Kinase TAM Receptors in Cutaneous Melanoma

by Pontara, Andrea, Paolino, Giovanni, Gregorc, Vanesa, Mercuri, Santo Raffaele, Bulotta, Alessandra, Bearzi, Pietro, Doglioni, Claudio, Rizzo, Nathalie
Published in Dermatol Pract Concept (2020)

Spontaneous Regression of Primary Melanoma and Multiple Melanocytic Nevi in a Patient With Metastatic Melanoma

by Paolino, Giovanni, Rizzo, Nathalie, Pampena, Riccardo, Bearzi, Pietro, Bulotta, Alessandra, Gregorc, Vanesa, Brianti, Pina, Moliterni, Elisa, Mercuri, Santo Raffaele
Published in Dermatol Pract Concept (2020)

Combination of immunotherapy with chemotherapy and radiotherapy in lung cancer: is this the beginning of the end for cancer?

by Lazzari, Chiara, Karachaliou, Niki, Bulotta, Alessandra, Viganó, Mariagrazia, Mirabile, Aurora, Brioschi, Elena, Santarpia, Mariacarmela, Gianni, Luca, Rosell, Rafael, Gregorc, Vanesa
Published in Ther Adv Med Oncol (2018)

NGR‐hTNF and Doxorubicin as Second‐Line Treatment of Patients with Small Cell Lung Cancer

by Gregorc, Vanesa, Cavina, Raffaele, Novello, Sivia, Grossi, Francesco, Lazzari, Chiara, Capelletto, Enrica, Genova, Carlo, Salini, Giulia, Lambiase, Antonio, Santoro, Armando
Published in Oncologist (2018)

PD-1 Inhibitors-Related Neurological Toxicities in Patients with Non-Small-Cell Lung Cancer: A Literature Review

by Mirabile, Aurora, Brioschi, Elena, Ducceschi, Monika, Piva, Sheila, Lazzari, Chiara, Bulotta, Alessandra, Viganò, Maria Grazia, Petrella, Giovanna, Gianni, Luca, Gregorc, Vanesa
Published in Cancers (Basel) (2019)

Prognostic Role of Positron Emission Tomography and Computed Tomography Parameters in Stage I Lung Adenocarcinoma

by Carretta, Angelo, Bandiera, Alessandro, Muriana, Piergiorgio, Viscardi, Stefano, Ciriaco, Paola, Gajate, Ana Maria Samanes, Arrigoni, Gianluigi, Lazzari, Chiara, Gregorc, Vanesa, Negri, Giampiero
Published in Radiol Oncol (2020)

Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence

by Mirabile, Aurora, Rivoltini, Licia, Daveri, Elena, Vernieri, Claudio, Mele, Roberto, Porcu, Luca, Lazzari, Chiara, Bulotta, Alessandra, Viganò, Maria Grazia, Cascinu, Stefano, Gregorc, Vanesa
Published in Cancers (Basel) (2020)

Next Generation Sequencing in Non-Small Cell Lung Cancer: Pitfalls and Opportunities

by Lazzari, Chiara, Bulotta, Alessandra, Cangi, Maria Giulia, Bucci, Gabriele, Pecciarini, Lorenza, Bonfiglio, Silvia, Lorusso, Vincenza, Ippati, Stefania, Arrigoni, Gianluigi, Grassini, Greta, Doglioni, Claudio, Gregorc, Vanesa
Published in Diagnostics (Basel) (2020)

History of Extensive Disease Small Cell Lung Cancer Treatment: Time to Raise the Bar? A Review of the Literature

by Lazzari, Chiara, Mirabile, Aurora, Bulotta, Alessandra, Viganó, Maria Grazia, Ogliari, Francesca Rita, Ippati, Stefania, Dell’Oca, Italo, Santarpia, Mariacarmela, Lorusso, Vincenza, Reck, Martin, Gregorc, Vanesa
Published in Cancers (Basel) (2021)

Chemotherapy versus erlotinib as second-line treatment in patients with advanced non-small cell lung cancer and wild-type epidermal growth factor receptor: an individual patient da...

by Garassino, Marina Chiara, Kawaguchi, Tomoya, Gregorc, Vanesa, Rulli, Eliana, Ando, Masahiko, Marsoni, Silvia, Isa, Shun-ichi, Novello, Silvia, Farina, Gabriella, Barni, Sandro, Torri, Valter, Cinquini, Michela
Published in ESMO Open (2018)